Skip to content
WuXi AppTec Logo White

Expert IND-enabling studies
for drug development

Get a comprehensive preclinical testing program that prepares and supports your molecule or new modality through IND-enabling studies and application submission. We provide fully integrated programs that address the bioanalytical, DMPK, and toxicology testing needs of your candidate and meet the demands of your IND submission timeline. 

Tell us more about your compound by filling out the form on the right and one of our experts will be in touch.
0 +
Active Clients
0 +
Global Bioanlytical Staff
0 K+
Global Clinical Trials Supported
0 M+
Bioanalytical Samples Analyzed/Year
0 +
Novel Compounds Supported/Year

Integrated bioanalysis programs. On-time delivery.

WuXi AppTec provides preclinical bioanalytical testing for small and large molecules and new modalities. Our state-of-the-art facilities and world-class testing platforms help developers get the critical testing data they need to ensure successful regulatory submission.

Small & Large Molecule

Customized studies that meet the regulatory data and timeline needs of your molecule.

New Modalities

Cutting-edge bioanalysis for PROTAC, oligonucleotide, ADCs, and other novel compounds.

Biomarkers

Vast, continuously growing list of validated biomarkers for small and large molecule candidates.

Discovery

Non-GLP bioanalysis that covers your discovery in vitro ADME, biology, PK, PD & TOX needs.

Preclinical

Regulated preclinical bioanalytical support that your compound needs for IND submission.

Clinical

Global clinical support and sample management for small & large molecule and innovator drugs.

Your end-to-end preclinical testing partner

WuXi AppTec’s bioanalytical services are fully integrated with our comprehensive testing platform and supported by the complementary capabilities of our DMPK and safety assessment service teams, saving you time and costs while yielding invaluable data and insights. With multidisciplinary experience, we can support the full scope of your development program, including IND and NDA submission.